Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Oct;44(4):588–591. doi: 10.1038/bjc.1981.231

Minor histocompatibility antigens do not enhance BALB/c anti-SV40 TASA response.

P Nanni, C de Giovanni, M C Galli, S Grilli, P L Lollini, G Nicoletti, G Prodi
PMCID: PMC2010789  PMID: 6271159

Full text

PDF
588

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boone C. W., Paranjpe M., Orme T., Gillette R. Virus-augmented tumor transplantation antigens: evidence for a Helper antigen mechanism. Int J Cancer. 1974 Apr 15;13(4):543–551. doi: 10.1002/ijc.2910130414. [DOI] [PubMed] [Google Scholar]
  2. Colnaghi M. I. Histocompatibility antigens acting as helper determinants for tumor-associated antigens of murine lymphosarcoma. Eur J Immunol. 1975 Apr;5(4):241–245. doi: 10.1002/eji.1830050404. [DOI] [PubMed] [Google Scholar]
  3. Colnaghi M. I., Ménard S., Pierotti M. A. In vivo resistance and in vitro cellular reactivity against lymphosarcoma cells in immunized mice. Tumori. 1978 Jul-Aug;64(4):371–382. doi: 10.1177/030089167806400404. [DOI] [PubMed] [Google Scholar]
  4. Di Marco A. T., Franceschi C., Prodi G. Helper activity of histocompatibility antigens on cell-mediated immunity. Eur J Immunol. 1972 Jun;2(3):240–242. doi: 10.1002/eji.1830020309. [DOI] [PubMed] [Google Scholar]
  5. Drapkin M. S., Appella E., Law L. W. Immunogenic properties of a soluble tumor-specific transplantation antigen induced by Simian virus 40. J Natl Cancer Inst. 1974 Jan;52(1):259–264. doi: 10.1093/jnci/52.1.259. [DOI] [PubMed] [Google Scholar]
  6. Galili N., Naor D., Asjö B., Klein G. Induction of immune responsiveness in a genetically low-responsive tumor-host combination by chemical modification of the immunogen. Eur J Immunol. 1976 Jul;6(7):473–476. doi: 10.1002/eji.1830060705. [DOI] [PubMed] [Google Scholar]
  7. Glaser M., Lotan R. Augmentation of specific tumor immunity against a syngeneic SV40-induced sarcoma in mice by retinoic acid. Cell Immunol. 1979 Jun;45(1):175–181. doi: 10.1016/0008-8749(79)90373-3. [DOI] [PubMed] [Google Scholar]
  8. Knowles B. B., Koncar M., Pfizenmaier K., Solter D., Aden D. P., Trinchieri G. Genetic control of the cytotoxic T cell response to SV40 tumor-associated specific antigen. J Immunol. 1979 May;122(5):1798–1806. [PubMed] [Google Scholar]
  9. Lake P., Douglas T. C. Recognition and genetic control of helper determinants for cell surface antigen Thy-1. Nature. 1978 Sep 21;275(5677):220–222. doi: 10.1038/275220a0. [DOI] [PubMed] [Google Scholar]
  10. Martin W. J., Wunderlich J. R., Fletcher F., Inman J. K. Enhanced immunogenicity of chemically-coated syngeneic tumor cells. Proc Natl Acad Sci U S A. 1971 Feb;68(2):469–472. doi: 10.1073/pnas.68.2.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Müllbacher A., Brenan M. Cytotoxic T-cell response to H-Y in 'non-responder' CBA mice. Nature. 1980 May 1;285(5759):34–36. doi: 10.1038/285034a0. [DOI] [PubMed] [Google Scholar]
  12. Shearer G. M. Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes. Eur J Immunol. 1974 Aug;4(8):527–533. doi: 10.1002/eji.1830040802. [DOI] [PubMed] [Google Scholar]
  13. Streilein J. W., Stein-Streilein J. Allogeneic reactions, "adjuvant effect" and response to weak transplantation antigens in hamsters. Fed Proc. 1978 May 15;37(7):2052–2054. [PubMed] [Google Scholar]
  14. Stutman O., Shen F. W., Boyse E. A. Ly phenotype of T cells cytotoxic for syngeneic mouse mammary tumors: evidence for T cell interactions. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5667–5671. doi: 10.1073/pnas.74.12.5667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ting C. C., Law L. W. Studies of H-2 restriction in cell-mediated cytotoxicity and transplantation immunity to Leukemia-associated antigens. J Immunol. 1977 Apr;118(4):1259–1264. [PubMed] [Google Scholar]
  16. Trinchieri G., Aden D. P., Knowles B. B. Cell-mediated cytotoxicity to SV40-specific tumour-associated antigens. Nature. 1976 May 27;261(5558):312–314. doi: 10.1038/261312a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES